Bristol Myers Squibb (BMS) Extends their COVID Patient Support Program
Posted: Jan 27, 2021
Bristol Myers Squibb (BMS) Extends their COVID Patient Support Program image

Many Americans are struggling financially amid the COVID pandemic, but companies like Bristol Myers Squibb are stepping up to help.  Here is a statement that BMS released this week.

As you know, many continue to face challenges resulting from the COVID-19 pandemic, including loss of health insurance and other financial stress. Therefore, we are pleased to share that the expanded patient support program that Bristol Myers Squibb (BMS) initially offered in April 2020 has been extended. In addition to our BMS patient support programs and the BMS Patient Assistance Foundation, we will continue to help eligible unemployed patients in the U.S. who have lost their health insurance due to the COVID-19 pandemic through the first six months of 2021.

BMS and the Bristol Myers Squibb Foundation are committed to meeting the needs of patients during crises and have a record of doing so. Our expansion of existing U.S. patient support programs is representative of our aspiration to ‘leave no patients behind.’ 

Highlights are captured below but for detailed Q&As around the program extension, please click here

• We expanded existing patient support programs to help eligible unemployed patients in the U.S. who have lost their health insurance due to the COVID-19 pandemic. 

• The expanded program offers access to Bristol Myers Squibb medicine for free, including some of its most widely prescribed products, as well as those prescribed via telehealth services (see complete list of medicines here).

• The expansion of our existing U.S. patient support programs builds on other relief measures BMS and the independent Bristol Myers Squibb Foundation already have made. 

Additional PSP features include:

• Immediate access for patients who have lost their employment and health insurance

• A simple, single point of entry 

• Streamlined enrollment process

• Vouchers to assist with continuity of care for several self-administered BMS medicines, for eligible patients 

Please do not hesitate to reach out with any questions. 


BMS Advocacy

Thank you BMS for caring for the patients that are being hit hardest by the Covid Pandemic.

The author Lora Jensen

about the author
Lora Jensen

Lora is an Editorial Contributor for the Myeloma Crowd and proud mom of 6 kids and 5 grandkids. In addition to supporting myeloma patients, she loves creating fun parties and activities for her grandkids to enjoy.

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Bristol Myers Squibb
Janssen Oncology

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation for Multiple Myeloma (formerly know as Myeloma Crowd) is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811